| Irinotecan studied in …STUDIED_INderived200 of 963show all (up to 200) |
|---|
| → studied in | NCT05382559Phase 1 · recruiting A Study of ASP3082 in Adults With Advanced Solid Tumors · 963 trials list this drug (181 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06219941Phase 2 · recruiting AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 · 963 trials list this drug (181 active) | — | — | Malignant Gastric Neoplasm,Malignant Biliary Tract Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07346157Phase 1/Phase 2 · recruiting Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease · 963 trials list this drug (181 active) | — | — | Medulloblastoma,Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621718Phase 3 · recruiting Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma,Pancreatic Adenosquamous Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595931Phase 1 · active not recruiting M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · 963 trials list this drug (181 active) | — | — | Malignant Solid Neoplasm,Malignant Lung Neoplasm,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05379595Phase 1/Phase 2 · recruiting A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05610163Phase 2/Phase 3 · active not recruiting Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation and Continuing Response · 963 trials list this drug (181 active) | — | — | Malignant Rectal Neoplasm,Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06662786Phase 3 · recruiting A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06750094Phase 3 · recruiting A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy · 963 trials list this drug (181 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07194044Phase 1 · recruiting Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes · 963 trials list this drug (181 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07271355Phase 3 · recruiting Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial · 963 trials list this drug (181 active) | — | — | Appendix Carcinoma,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05863195Phase 3 · recruiting Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial · 963 trials list this drug (181 active) | — | — | Colorectal Neoplasm,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172296Phase 3 · recruiting Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma · 963 trials list this drug (181 active) | — | — | Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995872Phase 1 · recruiting Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma · 963 trials list this drug (181 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07722754Phase 2 · recruiting Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial · 963 trials list this drug (181 active) | — | — | Neoplasm,Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07839819Phase 1/Phase 2 · not yet recruiting Study of PM54 in Combination With Cytotoxic and Targeted Agents in Adult Participants With Advanced Malignancies · 963 trials list this drug (181 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07409272Phase 3 · recruiting A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07415031Phase 2 · recruiting A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies · 963 trials list this drug (181 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05153239Phase 3 · completed Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) · 963 trials list this drug (181 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831369Phase 2 · recruiting VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma · 963 trials list this drug (181 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4,Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211675Phase 1/Phase 2 · active not recruiting NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab · 963 trials list this drug (181 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05438459Phase 1/Phase 2 · recruiting GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites · 963 trials list this drug (181 active) | — | — | Malignant Gastric Neoplasm,Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03533582Phase 3 · active not recruiting Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery · 963 trials list this drug (181 active) | — | — | Hepatoblastoma,Hepatocellular Malignant Neoplasm, Not Otherwise Specified,Childhood Hepatocellular Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05365581Phase 1 · recruiting A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Gastric Adenocarcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07381764Phase 2 · recruiting ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer" · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01356290Phase 2 · recruiting Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors · 963 trials list this drug (181 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514497Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Solid Neoplasm,Malignant Lung Neoplasm,Malignant Pancreatic Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07775287Phase 3 · recruiting Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2) · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06897644Phase 3 · recruiting Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer. · 963 trials list this drug (181 active) | — | — | Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03715933Phase 1 · recruiting Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas · 963 trials list this drug (181 active) | — | — | Ewing Sarcoma,Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04340141Phase 3 · active not recruiting Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma,Pancreatic Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05677490Phase 3 · recruiting mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma · 963 trials list this drug (181 active) | — | — | Esophageal Adenocarcinoma,Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541262Phase 1/Phase 2 · recruiting Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors · 963 trials list this drug (181 active) | — | — | Ewing Sarcoma,Liposarcoma,Osteosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05319730Phase 1/Phase 2 · recruiting A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B) · 963 trials list this drug (181 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07024615Phase 1 · recruiting A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer · 963 trials list this drug (181 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328425Phase 2 · recruiting Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS · 963 trials list this drug (181 active) | — | — | Desmoplastic Small Round Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07363408Phase 1 · not yet recruiting Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm,Microsatellite Stable Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05945823Phase 2 · active not recruiting Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Esophageal Squamous Cell Carcinoma,Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02567435Phase 3 · active not recruiting Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma · 963 trials list this drug (181 active) | — | — | Rhabdomyosarcoma,Alveolar Rhabdomyosarcoma,Embryonal Rhabdomyosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03366155Phase 2 · completed Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver · 963 trials list this drug (181 active) | — | — | Colorectal Adenocarcinoma,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06459180Phase 3 · active not recruiting A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20) · 963 trials list this drug (181 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528496Phase 2 · recruiting N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma · 963 trials list this drug (181 active) | — | — | Neuroblastoma,Childhood Neuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034173Phase 2 · terminated Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation · 963 trials list this drug (181 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07474727Phase 2 · recruiting A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00642603Phase 2 · terminated A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04329494Phase 1 · recruiting PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer · 963 trials list this drug (181 active) | — | — | Malignant Solid Neoplasm,Appendix Carcinoma,Gastric Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04322318Phase 2 · recruiting A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT · 963 trials list this drug (181 active) | — | — | Anaplastic Kidney Wilms Tumor,Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06401330Phase 3 · recruiting A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) · 963 trials list this drug (181 active) | — | — | Mixed Cell Type Kidney Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06958328Phase 3 · recruiting Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07466316Phase 3 · recruiting A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS) · 963 trials list this drug (181 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586515Phase 1 · recruiting MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors · 963 trials list this drug (181 active) | — | — | Lung Non-Small Cell Carcinoma,Malignant Colorectal Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06620302Phase 1/Phase 2 · suspended Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma · 963 trials list this drug (181 active) | — | — | Malignant Solid Neoplasm,Childhood Malignant Solid Neoplasm,Childhood Fibrolamellar Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04535401Phase 1 · active not recruiting Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines · 963 trials list this drug (181 active) | — | — | Digestive System Carcinoma,Gastric Carcinoma,Colorectal Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06011772early Phase 1 · active not recruiting EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820957Phase 2/Phase 3 · active not recruiting Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body · 963 trials list this drug (181 active) | — | — | Ewing Sarcoma,High Grade Sarcoma,Round Cell Sarcoma with EWSR1-non-ETS Fusion+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04008030Phase 3 · active not recruiting A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC) · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04205968Phase 2 · recruiting Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers · 963 trials list this drug (181 active) | — | — | Small Intestinal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06741644Phase 1/Phase 2 · recruiting A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors · 963 trials list this drug (181 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619313Phase 1 · recruiting AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Cholangiocarcinoma,Pancreatic Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07214298Phase 1/Phase 2 · recruiting Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045201Phase 1 · active not recruiting Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors · 963 trials list this drug (181 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05083481Phase 1 · terminated A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors · 963 trials list this drug (181 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05722327Phase 1 · active not recruiting Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01677884Phase 2 · completed Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy · 963 trials list this drug (181 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06139211Phase 1/Phase 2 · completed A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors · 963 trials list this drug (181 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07155200Phase 1/Phase 2 · recruiting Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial) · 963 trials list this drug (181 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04199026NA · recruiting Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma · 963 trials list this drug (181 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05999994Phase 2 · recruiting A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer · 963 trials list this drug (181 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01837862Phase 1/Phase 2 · active not recruiting A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas · 963 trials list this drug (181 active) | — | — | Anaplastic Astrocytoma,Glioblastoma,Glioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07748611Phase 2 · not yet recruiting SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial · 963 trials list this drug (181 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01394939Phase 1/Phase 2 · completed Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma · 963 trials list this drug (181 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06644781Phase 3 · recruiting A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) · 963 trials list this drug (181 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641313Phase 2 · active not recruiting Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer · 963 trials list this drug (181 active) | — | — | Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04657068Phase 1/Phase 2 · recruiting A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors · 963 trials list this drug (181 active) | — | — | Malignant Neoplasm,Acinar Cell Carcinoma,Malignant Fallopian Tube Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04743661Phase 2 · active not recruiting 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma · 963 trials list this drug (181 active) | — | — | Medulloblastoma,Ependymoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04776655Phase 3 · active not recruiting Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05253846Phase 2 · active not recruiting Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 · 963 trials list this drug (181 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07094893Phase 4 · not yet recruiting Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07582315Phase 3 · recruiting A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01) · 963 trials list this drug (181 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07606599Phase 3 · recruiting A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure · 963 trials list this drug (181 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05719558Phase 1 · recruiting A Study of ASP1002 in Adults for Treatment of Solid Tumors · 963 trials list this drug (181 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06304974Phase 3 · active not recruiting A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01) · 963 trials list this drug (181 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06974110Phase 1 · recruiting Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors · 963 trials list this drug (181 active) | — | — | Solid Neoplasm,Malignant Gastric Neoplasm,Malignant Colorectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07441369Phase 2 · enrolling by invitation Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer · 963 trials list this drug (181 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06450041Phase 2 · recruiting NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial · 963 trials list this drug (181 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607185Phase 1 · active not recruiting A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors · 963 trials list this drug (181 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma,Malignant Colorectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07712094Phase 2 · not yet recruiting AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer · 963 trials list this drug (181 active) | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07487896Phase 3 · recruiting A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line Therapy · 963 trials list this drug (181 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05652686Phase 1/Phase 2 · recruiting A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) · 963 trials list this drug (181 active) | — | — | Neuroendocrine Carcinoma,Extrapulmonary Neuroendocrine Carcinoma,Large Cell Neuroendocrine Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705919Phase 1/Phase 2 · not yet recruiting DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05669339Phase 2 · recruiting AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma · 963 trials list this drug (181 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07027748Phase 1 · recruiting Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma · 963 trials list this drug (181 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02813135Phase 1/Phase 2 · recruiting European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors · 963 trials list this drug (181 active) | — | — | Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07678593Phase 1/Phase 2 · not yet recruiting A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation · 963 trials list this drug (181 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06346392Phase 3 · active not recruiting AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 · 963 trials list this drug (181 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07518147Phase 3 · recruiting A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment · 963 trials list this drug (181 active) | — | — | Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03189706early Phase 1 · active not recruiting Study of Chemoimmunotherapy for High-Risk Neuroblastoma · 963 trials list this drug (181 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00980460Phase 3 · completed Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer · 963 trials list this drug (181 active) | — | — | PRETEXT I Hepatoblastoma,PRETEXT II Hepatoblastoma,PRETEXT III Hepatoblastoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07056777Phase 1/Phase 2 · recruiting Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04251715Phase 2 · terminated mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma · 963 trials list this drug (181 active) | — | — | Liver Carcinoma,Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079274Phase 3 · completed Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer · 963 trials list this drug (181 active) | — | — | Colon Adenocarcinoma,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03872947Phase 1 · active not recruiting A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors · 963 trials list this drug (181 active) | — | — | Solid Neoplasm,Melanoma,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07662031Phase 2 · not yet recruiting Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05843188Phase 2 · active not recruiting Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05694715Phase 1 · recruiting Combination Therapy in Cancers With Mutations in DNA Repair Genes · 963 trials list this drug (181 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06381154Phase 2 · active not recruiting Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01871766Phase 2 · active not recruiting Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy · 963 trials list this drug (181 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07649655Phase 1 · not yet recruiting EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04607421Phase 3 · active not recruiting A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05235542Phase 1/Phase 2 · completed A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors · 963 trials list this drug (181 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04587128Phase 2 · active not recruiting Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04879368Phase 3 · completed RegoNivo vs Standard of Care Chemotherapy in AGOC · 963 trials list this drug (181 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492999Phase 2 · active not recruiting Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver · 963 trials list this drug (181 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04753879Phase 2 · active not recruiting Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04796012Phase 1/Phase 2 · recruiting VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors · 963 trials list this drug (181 active) | — | — | Solid Neoplasm,Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625320Phase 3 · active not recruiting Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077285Phase 2 · active not recruiting Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma · 963 trials list this drug (181 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05239741Phase 3 · active not recruiting Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66) · 963 trials list this drug (181 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800587Phase 2 · recruiting Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer · 963 trials list this drug (181 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06998940Phase 3 · recruiting Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890355Phase 2 · completed FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Pancreatic Neoplasm,Pancreatic Carcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06006273Phase 1 · recruiting A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors · 963 trials list this drug (181 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04901702Phase 1/Phase 2 · recruiting Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma · 963 trials list this drug (181 active) | — | — | Solid Neoplasm,Hepatoblastoma,Malignant Germ Cell Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03279237Phase 1 · completed A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers · 963 trials list this drug (181 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04927780Phase 3 · active not recruiting Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03017326Phase 3 · active not recruiting Paediatric Hepatic International Tumour Trial · 963 trials list this drug (181 active) | — | — | Hepatoblastoma,Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02308527Phase 2 · completed Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children · 963 trials list this drug (181 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02192359Phase 1 · active not recruiting Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas · 963 trials list this drug (181 active) | — | — | Anaplastic Astrocytoma,Anaplastic Oligoastrocytoma,Anaplastic Oligodendroglioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04920032Phase 1 · recruiting Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm,Colon Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03554707early Phase 1 · withdrawn SGT-53 in Children With Recurrent or Progressive CNS Malignancies · 963 trials list this drug (181 active) | — | — | Childhood Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06094140Phase 2 · active not recruiting NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06941857Phase 2 · recruiting NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04481204Phase 2 · withdrawn New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study · 963 trials list this drug (181 active) | — | — | Pancreatic Adenocarcinoma,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06846346Phase 2 · recruiting Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma · 963 trials list this drug (181 active) | — | — | Esophageal Adenocarcinoma,Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787500Phase 1 · completed Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery · 963 trials list this drug (181 active) | — | — | Solid Neoplasm,Malignant Solid Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07543744Phase 1 · recruiting A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01864109Phase 2 · active not recruiting Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma · 963 trials list this drug (181 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02143219Phase 2 · completed Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093353Phase 1 · completed N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma · 963 trials list this drug (181 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00509353Phase 1 · completed N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma · 963 trials list this drug (181 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04924192Phase 2 · terminated A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer · 963 trials list this drug (181 active) | — | — | Lung Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05440786Phase 2 · active not recruiting CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma · 963 trials list this drug (181 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06417476Phase 2 · active not recruiting Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer · 963 trials list this drug (181 active) | — | — | Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00213486Phase 2 · completed Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial · 963 trials list this drug (181 active) | — | — | Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03678883Phase 2 · active not recruiting 9-ING-41 in Patients With Advanced Cancers · 963 trials list this drug (181 active) | — | — | Neoplasm,Breast Neoplasm,Malignant Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02366819Phase 4 · suspended Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer · 963 trials list this drug (181 active) | — | — | Malignant Gastric Neoplasm,Esophageal Adenocarcinoma,Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05838768Phase 1 · active not recruiting Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. · 963 trials list this drug (181 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05384821Phase 1/Phase 2 · recruiting Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) · 963 trials list this drug (181 active) | — | — | Wilms Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02047474Phase 2 · completed Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Neoplasm,Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05846867Phase 1/Phase 2 · active not recruiting A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06951503Phase 3 · recruiting AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04094688Phase 3 · active not recruiting Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Colorectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04238819Phase 1/Phase 2 · completed A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma · 963 trials list this drug (181 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06356311Phase 3 · active not recruiting A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) · 963 trials list this drug (181 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04697628Phase 3 · completed Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer · 963 trials list this drug (181 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02021422Phase 1 · completed A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy · 963 trials list this drug (181 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03794349Phase 2 · active not recruiting Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma · 963 trials list this drug (181 active) | — | — | Neuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03365882Phase 2 · completed S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery · 963 trials list this drug (181 active) | — | — | Colon Adenocarcinoma,Colon Carcinoma,Malignant Colon Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04109924Phase 2 · completed TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study · 963 trials list this drug (181 active) | — | — | Colorectal Adenocarcinoma,Colorectal Carcinoma,Malignant Colorectal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03693807Phase 2 · completed A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma · 963 trials list this drug (181 active) | — | — | Cholangiocarcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05412082Phase 1 · recruiting SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00556413Phase 2 · completed Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06771622Phase 1/Phase 2 · active not recruiting Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors · 963 trials list this drug (181 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05062889Phase 2 · suspended Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients · 963 trials list this drug (181 active) | — | — | Colon Neoplasm,Malignant Colon Neoplasm,RAS Wild-Type Colon Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06208657Phase 1/Phase 2 · recruiting Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer · 963 trials list this drug (181 active) | — | — | Malignant Neoplasm,Childhood Malignant Neoplasm,Childhood Solid Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07364422Phase 1/Phase 2 · not yet recruiting To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer · 963 trials list this drug (181 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04342910Phase 3 · recruiting Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC · 963 trials list this drug (181 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04539808Phase 2 · active not recruiting NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03977233Phase 2 · recruiting Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Neoplasm,Pancreatic Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04689347Phase 1/Phase 2 · recruiting 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer. · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07334301Phase 1/Phase 2 · recruiting A Multi-Arm, Platform Trial For Relapsed Neuroblastoma · 963 trials list this drug (181 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03290937Phase 1 · completed Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03443492Phase 2 · completed SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07309185Phase 2 · recruiting Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy · 963 trials list this drug (181 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01858168Phase 1 · completed Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma · 963 trials list this drug (181 active) | — | — | Ewing Sarcoma,Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06509906Phase 1 · terminated M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511) · 963 trials list this drug (181 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04067115Phase 1/Phase 2 · completed SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients · 963 trials list this drug (181 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05342636Phase 1/Phase 2 · completed A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A) · 963 trials list this drug (181 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714357Phase 2 · recruiting ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05391126NA · recruiting GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06107413Phase 2 · active not recruiting Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06733038Phase 3 · recruiting FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients. · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03829462Phase 3 · active not recruiting Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05417386Phase 1 · terminated FOLFIRINOX + NIS793 in Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Carcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02967289Phase 3 · completed IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting · 963 trials list this drug (181 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04821284Phase 1/Phase 2 · active not recruiting Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04385277Phase 2 · active not recruiting Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL) · 963 trials list this drug (181 active) | — | — | Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05382442Phase 2 · active not recruiting A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03184870Phase 1/Phase 2 · completed A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors · 963 trials list this drug (181 active) | — | — | Malignant Pancreatic Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04361708Phase 1 · recruiting Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies · 963 trials list this drug (181 active) | — | — | Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05022654Phase 2 · active not recruiting SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma. · 963 trials list this drug (181 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07150247Phase 2 · recruiting Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05678257Phase 2 · terminated A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Colorectal Neoplasm,Colon Neoplasm,Colorectal Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07150403Phase 2 · not yet recruiting Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06490536Phase 3 · recruiting The Sagittarius Trial · 963 trials list this drug (181 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02605265Phase 3 · completed Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1 · 963 trials list this drug (181 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07134205Phase 3 · not yet recruiting The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer · 963 trials list this drug (181 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04141995Phase 2 · terminated FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer · 963 trials list this drug (181 active) | — | — | Pancreatic Carcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03493048Phase 2 · active not recruiting Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM · 963 trials list this drug (181 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03797625Phase 2 · completed Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas · 963 trials list this drug (181 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |